Identifying Recipients of Electroconvulsive Therapy: Data From Privately Insured Americans
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Despite the effectiveness of electroconvulsive therapy (ECT), limited epidemiologic research has been conducted to identify rates of ECT use and characteristics of patients who receive ECT. Sociodemographic and clinical characteristics associated with ECT use were examined among patients with mood disorders in the MarketScan commercial insurance claims database. METHODS: Among individuals with major depressive disorder or bipolar disorder, sociodemographic and clinical characteristics of those who received ECT and those who did not were compared by using bivariate effect size comparisons and multivariate logistic regression. RESULTS: Among unique individuals in the 2014 MarketScan database (N=47,258,528), the ECT utilization rate was 5.56 ECT patients per 100,000 in the population. Of the 969,277 patients with a mood disorder, 2,471 (.25%) received ECT. Those who received ECT had substantially higher rates of additional comorbid psychiatric disorders (risk ratio [RR]=5.70 for any additional psychiatric disorder), numbers of prescription fills for any psychotropic medication (Cohen's d=.77), rates of any substance use disorder (RR=1.97), and total outpatient psychotherapy visits (Cohen's d=.49). The proportion of patients with a mood disorder who received ECT in the West (.19%) was substantially lower than in other U.S. regions (.28%). This difference was almost entirely accounted for by one western state comprising 59.1% of patients in that region. CONCLUSIONS: Use of ECT is exceptionally uncommon and limited to patients with extensive multimorbidity and high levels of service use. ECT utilization is most limited in areas of the country where regulatory restrictions are greatest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An effect size primer: A guide for clinicians and researchers.
Ferguson, C. J. (2009) · Professional Psychology: Research and Practice · doi:10.1037/a0015808 · Cited by 3,467 · cited 1×
“These values are based on conventional definitions of small and medium effect sizes for Cohen’s d (18) and on a conventional definition of a “practically” significant effect for relative risk (19).”
MethodDiagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380 · cited 1×
“Especially among adults with treatment-resistant depression, generally defined as depression that does not remit or respond to one or more standard antidepressant pharmacotherapies (3), ECT stands”
BackgroundSackeim, H. A., Haskett, R. F., Mulsant, B. H., Thase, M. E., Mann, J. J., Pettinati, H. M., Greenberg, R. M., Crowe, R. R., Cooper, T. B., & Prudic, J. (2001) · JAMA · doi:10.1001/jama.285.10.1299 · Cited by 686 · cited 1×
“This finding could be due to the higher rate of lithium use in the ECT group, a common medication prescribed for bipolar disorder as well as in the specific context of ECT because of its ability to reduce the risk of relapse after ECT (22).”
BackgroundSackeim, H. A., Prudic, J., Nobler, M. S., Fitzsimons, L., Lisanby, S. H., Payne, N., Berman, R. M., Brakemeier, E.-L., Perera, T., & Devanand, D. P. (2008) · Brain Stimulation · doi:10.1016/j.brs.2008.03.001 · Cited by 542 · cited 2×
“Given the marked improvements in the cognitive side-effect profile of ECT in recent decades (right unilateral site and shorter pulse width) (8,30,31), there is much room for improvement in making this effective treatment more widely available to a broad range of appropriate patients.”
BackgroundO'Connor, M. K., Knapp, R., Husain, M., Rummans, T. A., Petrides, G., Smith, G., Mueller, M., Snyder, K., Bernstein, H., Rush, A. J., et al. (2001) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200111000-00006 · Cited by 279 · cited 1×
“27), we included it as a dichotomous independent variable (above the median age of 44) on the basis of substantial prior literature indicating that older patients may be more likely to respond to ECT (20,21).”
MethodAssociation of Electroconvulsive Therapy With Psychiatric Readmissions in US Hospitals
Slade, E. P., Jahn, D. R., Regenold, W. T., & Case, B. G. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1378 · Cited by 135 · cited 4×
“Such a decline and limited use are problematic, given the considerable evidence that ECT is the most effective therapy for treatment-resistant depression (5), can rapidly reduce suicidal ideation (29), and may be associated with a lower rate of 30-day psychiatric hospital readmission (6).”
BackgroundInfluentialA comparison of RUL ultrabrief pulse (0.3 ms) ECT and standard RUL ECT
Loo, C. K., Sainsbury, K., Sheehan, P., & Lyndon, B. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009292 · Cited by 127
Cited by
Prognosis and improved outcomes in major depression: a review
Kraus, C., Kadriu, B., Lanzenberger, R., Zarate, C. A., & Kasper, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0460-3 · Cited by 482
Management of Treatment-Resistant Depression: Challenges and Strategies
Voineskos, D., Daskalakis, Z. J., & Blumberger, D. M. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s198774 · Cited by 446
“142 This gross underutilization of ECT persists, despite signi fi cant progress in reducing the cognitive side effect pro fi le and alterations in the method of ECT, including seizure threshold titration, inclusion of highly tolerable anaesthetic agents and improvements in peri-procedural care.”
Espinoza, R. T., & Kellner, C. H. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2034954 · Cited by 321
When to consider electroconvulsive therapy (ECT)
Kellner, C. H., Obbels, J., & Sienaert, P. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13134 · Cited by 239
“In the United States, ECT has generally been reserved for patients with prominent affective or catatonic symptoms, a history of previous response to ECT, or neuroleptic malignant syndrome (27).”
BackgroundInfluentialBahji, A., Hawken, E. R., Sepehry, A. A., Cabrera, C. A., & Vazquez, G. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12994 · Cited by 159
“25% of patients with MDD or BDD receive ECT in the USA, which could be considered a significant underutilization (62).”
BackgroundInfluential
Metadata
- Authors
- Wilkinson, S. T., Agbese, E., Leslie, D. L., & Rosenheck, R. A.
- Venue
- Psychiatric Services
- Published
- 2018-05-01
- Volume
- 69
- Issue
- 5
- Pages
- 542-548
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2792270412
- Cited by
- 106
- References
- 7
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identifying Recipients of Electroconvulsive Therapy: Data From Privately Insured Americans. https://app.cochat.ai/papers/10.1176/appi.ps.201700364
- The paper
- Wilkinson, S. T., Agbese, E., Leslie, D. L., & Rosenheck, R. A. (2018). Identifying Recipients of Electroconvulsive Therapy: Data From Privately Insured Americans. Psychiatric Services. https://doi.org/10.1176/appi.ps.201700364
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.